{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:36:26Z","timestamp":1791905786635,"version":"4.3.4"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"vor","delay-in-days":365,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.cmi.2015.11.006","type":"journal-article","created":{"date-parts":[[2015,11,25]],"date-time":"2015-11-25T16:58:06Z","timestamp":1448470686000},"page":"289.e1-289.e7","source":"Crossref","is-referenced-by-count":24,"title":["Response to antiviral therapy in haematopoietic stem cell transplant recipients with cytomegalovirus (CMV) reactivation according to the donor CMV serological status"],"prefix":"10.1016","volume":"22","author":[{"given":"S.","family":"Servais","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Dumontier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Biard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Schnepf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Resche-Rigon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Peffault de Latour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Scieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Robin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Meunier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Xhaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Sicre de Fontbrune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Le Goff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Soci\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.-C.","family":"Mazeron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2015.11.006_bib1","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.1182\/blood-2002-10-3263","article-title":"Donor CMV serologic status and outcome of CMV-seropositive recipients after unrelated donor stem cell transplantation: an EBMT megafile analysis","volume":"102","author":"Ljungman","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.cmi.2015.11.006_bib2","doi-asserted-by":"crossref","first-page":"e144","DOI":"10.1093\/cid\/cir002","article-title":"Influence of donor cytomegalovirus (CMV) status on severity of viral reactivation after allogeneic stem cell transplantation in CMV-seropositive recipients","volume":"52","author":"Pietersma","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2015.11.006_bib3","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/sj.bmt.1705699","article-title":"Risk factors associated with late cytomegalovirus reactivation after allogeneic stem cell transplantation for hematological malignancies","volume":"40","author":"\u00d6zdemir","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.cmi.2015.11.006_bib4","doi-asserted-by":"crossref","first-page":"6465","DOI":"10.1182\/blood-2009-02-203307","article-title":"Impact of donor CMV status on viral infection and reconstitution of multifunction CMV-specific T cells in CMV-positive transplant recipients","volume":"113","author":"Zhou","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.cmi.2015.11.006_bib5","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1038\/bmt.2008.120","article-title":"CMV infections after hematopoietic stem cell transplantation","volume":"42","author":"Ljungman","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.cmi.2015.11.006_bib6","doi-asserted-by":"crossref","first-page":"5711","DOI":"10.1182\/blood-2008-10-143560","article-title":"How we treat CMV in hematopoietic cell transplant recipients","volume":"113","author":"Boeckh","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.cmi.2015.11.006_bib7","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1128\/CMR.00009-10","article-title":"Antiviral drug resistance of cytomegalovirus","volume":"34","author":"Lurain","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.cmi.2015.11.006_bib8","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.hoc.2010.11.011","article-title":"Cytomegalovirus in hematopoietic stem cell transplant recipients","volume":"25","author":"Ljungman","year":"2011","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.cmi.2015.11.006_bib9","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1086\/587106","article-title":"Artesunate as a potent antiviral agent in a patient with late drug-resistant cytomegalovirus infection after hematopoietic stem cell transplantation","volume":"46","author":"Shapira","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2015.11.006_bib10","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jcv.2013.10.007","article-title":"Dynamics of cytomegalovirus populations harboring mutations in genes UL54 and UL97 in a hematopoietic stem cell transplant recipient","volume":"58","author":"Schnepf","year":"2013","journal-title":"J\u00a0Clin Virol"},{"key":"10.1016\/j.cmi.2015.11.006_bib11","doi-asserted-by":"crossref","first-page":"e41648","DOI":"10.1371\/journal.pone.0041648","article-title":"Monitoring of human cytomegalovirus and virus-specific T-cell response in young patients receiving allogeneic hematopoietic stem cell transplantation","volume":"7","author":"Lilleri","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.cmi.2015.11.006_bib12","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1128\/JCM.00067-13","article-title":"Fully automated quantification of cytomegalovirus (CMV) in whole blood with the new sensitive Abbott RealTime CMV assay in the era of the CMV international standard","volume":"51","author":"Schnepf","year":"2013","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2015.11.006_bib13","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1093\/jac\/dkq368","article-title":"Drug resistant cytomegalovirus in transplant recipients: a French cohort study","volume":"65","author":"Hantz","year":"2010","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2015.11.006_bib14","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/j.bbmt.2011.08.014","article-title":"Dynamics of cytomegalovirus (CMV) plasma DNAemia in initial and recurrent episodes of active CMV infection in the allogeneic stem cell transplantation setting: implications for designing preemptive antiviral therapy strategies","volume":"17","author":"Mu\u00f1oz-Cobo","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.cmi.2015.11.006_bib15","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1084\/jem.190.2.177","article-title":"The dynamics of human cytomegalovirus replication in\u00a0vivo","volume":"190","author":"Emery","year":"1999","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.cmi.2015.11.006_bib16","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3851\/IMP1899","article-title":"Failure of pre-emptive treatment of cytomegalovirus infections and antiviral resistance in stem cell transplant recipients","volume":"17","author":"van der Beek","year":"2012","journal-title":"Antiviral Ther"},{"key":"10.1016\/j.cmi.2015.11.006_bib17","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jcv.2010.06.018","article-title":"Human cytomegalovirus (HCMV) replication kinetics in stem cell transplant recipients following anti-HCMV therapy","volume":"49","author":"Buyck","year":"2010","journal-title":"J\u00a0Clin Virol"},{"key":"10.1016\/j.cmi.2015.11.006_bib18","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1182\/blood.V99.6.1978","article-title":"Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, a matched control study","volume":"99","author":"Junghanss","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.cmi.2015.11.006_bib19","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.bbmt.2009.02.009","article-title":"Effect of conditioning regimen intensity on CMV infection in allogeneic hematopoietic cell transplantation","volume":"15","author":"Nakamae","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.cmi.2015.11.006_bib20","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1756-8722-5-46","article-title":"Effects of intensified conditioning on Epstein\u2013Barr virus and cytomegalovirus infections in allogeneic hematopoietic stem cell transplantation for hematological malignancies","volume":"5","author":"Xuan","year":"2012","journal-title":"J\u00a0Hematol Oncol"},{"key":"10.1016\/j.cmi.2015.11.006_bib21","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1182\/blood.V67.4.1162.1162","article-title":"Cytomegalovirus infection after bone marrow transplantation: an association with acute graft-versus-host disease","volume":"67","author":"Miller","year":"1986","journal-title":"Blood"},{"key":"10.1016\/j.cmi.2015.11.006_bib22","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1086\/591185","article-title":"Patterns of cytomegalovirus reactivation are associated with distinct evolutive profiles of immune reconstitution after allogeneic hematopoietic stem cell transplantation","volume":"198","author":"Moins-Teisserenc","year":"2008","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cmi.2015.11.006_bib23","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/bmt.2009.172","article-title":"Lack of prompt expansion of cytomegalovirus pp65 and IE-1 specific IFN gamma CD8+ and CD4+ cells is associated with rising levels of pp65antigenemia and DNAemia during pre-emptive therapy in allogeneic hematopoietic stem cell transplant recipients","volume":"45","author":"Tormo","year":"2010","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.cmi.2015.11.006_bib24","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1093\/jac\/dkn521","article-title":"Valganciclovir as pre-emptive therapy for cytomegalovirus infection post-allogenic stem cell transplantation: implications for the emergence of drug-resistant cytomegalovirus","volume":"63","author":"Allice","year":"2009","journal-title":"J\u00a0Antimicrobial Chemother"},{"key":"10.1016\/j.cmi.2015.11.006_bib25","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/infdis\/jit475","article-title":"High rate of cytomegalovirus drug resistance in patients receiving antiviral treatment after haploidentical stem cell transplantation","volume":"209","author":"Shmueli","year":"2014","journal-title":"J\u00a0Infect Dis"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X1500988X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X1500988X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T21:48:34Z","timestamp":1599860914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X1500988X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S1198743X1500988X"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2015.11.006","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]}}}